These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24699354)

  • 21. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.
    Mishra DN; Bindal M; Singh SK; Vijaya Kumar SG
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):99-102. PubMed ID: 16394558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of mouth dissolving tablets of the Etoricoxib.
    Chandira RM; Venkataeswarlu BS; Kumudhavalli MV; Debjitbhowmik ; Jayakar B
    Pak J Pharm Sci; 2010 Apr; 23(2):178-81. PubMed ID: 20363696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.
    Bowles BJ; Dziemidowicz K; Lopez FL; Orlu M; Tuleu C; Edwards AJ; Ernest TB
    AAPS PharmSciTech; 2018 Aug; 19(6):2598-2609. PubMed ID: 29916193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral disintegrating tablets. A new, modern, solid dosage form].
    Popa G; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):337-42. PubMed ID: 14755937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.
    Al-Khattawi A; Koner J; Rue P; Kirby D; Perrie Y; Rajabi-Siahboomi A; Mohammed AR
    Eur J Pharm Biopharm; 2015 Aug; 94():1-10. PubMed ID: 25960332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orally disintegrating systems: innovations in formulation and technology.
    Goel H; Rai P; Rana V; Tiwary AK
    Recent Pat Drug Deliv Formul; 2008; 2(3):258-74. PubMed ID: 19075912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by Three-Dimensional Printing.
    Yu DG; Shen XX; Branford-White C; Zhu LM; White K; Yang XL
    J Pharm Pharmacol; 2009 Mar; 61(3):323-9. PubMed ID: 19222904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
    Rahman Z; Siddiqui A; Khan MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
    Late SG; Yu YY; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):4-11. PubMed ID: 18778759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of named binders in Rauwolfia vomitoria root tablets.
    Onunkwo GC
    Boll Chim Farm; 2000; 139(3):132-9. PubMed ID: 10961024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of promethazine theoclate fast dissolving tablet using pore forming technology by 3-factor, 3-level response surface-full factorial design.
    Sharma S; Sharma N; Das Gupta G
    Arch Pharm Res; 2010 Aug; 33(8):1199-207. PubMed ID: 20803123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varying efficacy of superdisintegrants in orally disintegrating tablets among different manufacturers.
    Mittapalli RK; Qhattal HS; Lockman PR; Yamsani MR
    Pharmazie; 2010 Nov; 65(11):805-10. PubMed ID: 21155386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
    Assaf SM; Qandil AM; Al-Ani EA
    Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.